Le rapport « Place des vaccins bivalents contre la Covid-19 Comirnaty Original/Omicron BA.1 et Comirnaty Original/Omicron BA.4-BA.5 », ci-joint, est adopté
See also
Vaccine recommendation
20/09/2022
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
s0tWcSESqgRp8zH5
